Ready for Launch in Gastroesophageal Adenocarcinoma: Anti-HER2 Innovation in First-Line Management

Is your gastroesophageal adenocarcinoma (GEA) treatment plan ready for the latest human epidermal growth factor receptor 2 (HER2) innovations? Credit available for this activity expires: 05/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/ready-launch-gastroesophageal-adenocarcinoma-anti-her2-2026a1000gtw?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Jun 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Ready for Launch in Gastroesophageal Adenocarcinoma: Anti-HER2 Innovation in First-Line Management

0:00 35:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 35 minutes long.

When was this Keeping Current CME episode published?

This episode was published on June 1, 2026.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!